| - GRCh37:
- Chr7:140453135-140453136
- GRCh38:
- Chr7:140753335-140753336
| BRAF | V512D, V548D, V563D, V566D, V578D, V600D, V603D, V640D | Melanoma | Uncertain significance (Mar 28, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr2:25463248
- GRCh38:
- Chr2:25240379
| DNMT3A | R749C, R597C, R526C, R560C | Tatton-Brown-Rahman overgrowth syndrome | Pathogenic (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr13:32910555
- GRCh38:
- Chr13:32336418
| BRCA2 | Y688C | Melanoma, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
| Conflicting interpretations of pathogenicity (Mar 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:21971161
- GRCh38:
- Chr9:21971162
| CDKN2A | H66P, H15P | Melanoma, Hereditary cancer-predisposing syndrome, not provided
| Uncertain significance (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:6426892
- GRCh38:
- Chr7:6387261
| RAC1 | P29S | Malignant neoplasm of body of uterus, Squamous cell carcinoma of the skin, Malignant melanoma of skin, Squamous cell carcinoma of the head and neck | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr1:11184580
- GRCh38:
- Chr1:11124523
| MTOR | P2213S | Melanoma | not provided (Mar 10, 2016) | no assertion provided |
| - GRCh37:
- Chr1:11188519
- GRCh38:
- Chr1:11128462
| MTOR | H1968Y | Melanoma | not provided (Mar 10, 2016) | no assertion provided |
| - GRCh37:
- Chr7:140481411
- GRCh38:
- Chr7:140781611
| BRAF | G466A, G378A, G414A, G429A, G432A, G444A, G469A, G506A | Melanoma, Malignant melanoma of skin, Neoplasm of the large intestine, Multiple myeloma, Squamous cell lung carcinoma, Lung adenocarcinoma, Squamous cell carcinoma of the head and neck | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453151
- GRCh38:
- Chr7:140753351
| BRAF | F595S, F507S, F543S, F558S, F561S, F573S, F598S, F635S | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453137
- GRCh38:
- Chr7:140753337
| BRAF | V600L, V512L, V548L, V563L, V566L, V578L, V603L, V640L | Cardiofaciocutaneous syndrome 1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr7:140453136
- GRCh38:
- Chr7:140753336
| BRAF | V600A, V512A, V548A, V563A, V566A, V578A, V603A, V640A | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453132-140453134
- GRCh38:
- Chr7:140753332-140753334
| BRAF | K601del, K513del, K549del, K564del, K567del, K579del, K604del, K641del | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453132
- GRCh38:
- Chr7:140753332
| BRAF | K601N, K513N, K549N, K564N, K567N, K579N, K604N, K641N | RASopathy | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr7:140453132
- GRCh38:
- Chr7:140753332
| BRAF | K601N, K513N, K549N, K564N, K567N, K579N, K604N, K641N | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453121-140453122
- GRCh38:
- Chr7:140753321-140753322
| BRAF | S605F, S517F, S553F, S568F, S571F, S583F, S608F, S645F | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453121
- GRCh38:
- Chr7:140753321
| BRAF | S605N, S517N, S553N, S568N, S571N, S583N, S608N, S645N | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr4:55599348
- GRCh38:
- Chr4:54733182
| KIT | V825A, V821A, V820A, V822A, V824A, V826A | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266122
- GRCh38:
- Chr3:41224631
| CTNNB1, LOC126806658 | T40I, T33I | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266098
- GRCh38:
- Chr3:41224607
| CTNNB1, LOC126806658 | D32A, D25A | Neoplasm of uterine cervix, Melanoma, Gastric adenocarcinoma, Prostate adenocarcinoma, Malignant neoplasm of body of uterus, Malignant melanoma of skin, Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder
| Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266074-41266097
- GRCh38:
- Chr3:41224583-41224606
| CTNNB1, LOC126806658 | | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266068
- GRCh38:
- Chr3:41224577
| CTNNB1, LOC126806658 | V22A, V15A | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266066-41266116
- GRCh38:
- Chr3:41224575-41224625
| CTNNB1, LOC126806658 | | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266064
- GRCh38:
- Chr3:41224573
| CTNNB1, LOC126806658 | A21T, A14T | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266040
- GRCh38:
- Chr3:41224549
| CTNNB1, LOC126806658 | A13T, A6T | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr1:115256529-115256530
- GRCh38:
- Chr1:114713908-114713909
| NRAS | Q61R | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr3:12641195
- GRCh38:
- Chr3:12599696
| RAF1 | W368S, W287S, W388S, W307S, W335S, W254S | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55152126
- GRCh38:
- Chr4:54285959
| PDGFRA | G853D, G866D, G878D | Gastrointestinal stroma tumor | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55152101
- GRCh38:
- Chr4:54285934
| PDGFRA | H845Y, H858Y, H870Y | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55152090
- GRCh38:
- Chr4:54285923
| PDGFRA | R841K, R854K, R866K | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55144144
- GRCh38:
- Chr4:54277977
| PDGFRA | V658A, V671A, V683A | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55141083
- GRCh38:
- Chr4:54274916
| PDGFRA | P577S, P602S, P590S | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr19:4117617
- GRCh38:
- Chr19:4117619
| MAP2K2 | V35M | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr19:4117584
- GRCh38:
- Chr19:4117586
| MAP2K2 | L46F | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr19:4117541
- GRCh38:
- Chr19:4117543
| MAP2K2 | Q60P | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr19:4110584
- GRCh38:
- Chr19:4110586
| MAP2K2 | C125S | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr19:4110581
- GRCh38:
- Chr19:4110583
| MAP2K2 | N126D | Cardiofaciocutaneous syndrome 4, RASopathy | Pathogenic/Likely pathogenic (Aug 19, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66729177
- GRCh38:
- Chr15:66436839
| MAP2K1 | F129L | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727455
- GRCh38:
- Chr15:66435117
| MAP2K1 | K57N | Melanoma, Prostate adenocarcinoma, Gastric adenocarcinoma, Malignant melanoma of skin, Lung adenocarcinoma, Non-Hodgkin lymphoma, Squamous cell carcinoma of the head and neck | Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727453
- GRCh38:
- Chr15:66435115
| MAP2K1 | K57E | Melanoma, Melorheostosis | Pathogenic/Likely pathogenic (Jun 23, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:212570064
- GRCh38:
- Chr2:211705339
| ERBB4 | R393W | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:212537981
- GRCh38:
- Chr2:211673256
| ERBB4 | E542K | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:212295699
- GRCh38:
- Chr2:211430974
| ERBB4 | E872K | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453133
- GRCh38:
- Chr7:140753333
| BRAF | K601R, K513R, K549R, K564R, K567R, K579R, K604R, K641R | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr14:105243048
- GRCh38:
- Chr14:104776711
| AKT1 | Q79K | Melanoma | Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr7:140481478
- GRCh38:
- Chr7:140781678
| BRAF | R444W, R356W, R392W, R407W, R410W, R422W, R447W, R484W | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140481411
- GRCh38:
- Chr7:140781611
| BRAF | G466E, G378E, G414E, G429E, G432E, G444E, G469E, G506E | Noonan syndrome 7, RASopathy | Conflicting interpretations of pathogenicity (Jan 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr7:140481402-140481403
- GRCh38:
- Chr7:140781602-140781603
| BRAF | G469S, G381S, G417S, G432S, G435S, G447S, G472S, G509S | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453161
- GRCh38:
- Chr7:140753361
| BRAF | I592V, I504V, I540V, I555V, I558V, I570V, I595V, I632V | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453154
- GRCh38:
- Chr7:140753354
| BRAF | D594A, D506A, D542A, D557A, D560A, D572A, D597A, D634A | Melanoma | Likely pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453135-140453136
- GRCh38:
- Chr7:140753335-140753336
| BRAF | V600E, V512E, V548E, V563E, V566E, V578E, V603E, V640E | Melanoma, Colonic neoplasm | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr4:55594258
- GRCh38:
- Chr4:54728092
| KIT | V654E, V650E, V651E, V655E | Melanoma | Likely pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr3:41266097
- GRCh38:
- Chr3:41224606
| CTNNB1, LOC126806658 | D32H, D25H | Neoplasm of uterine cervix, Prostate adenocarcinoma, Malignant neoplasm of body of uterus, Gastric adenocarcinoma, Malignant melanoma of skin, Medulloblastoma, Melanoma, Hepatocellular carcinoma, Transitional cell carcinoma of the bladder
| Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr1:115258730
- GRCh38:
- Chr1:114716109
| NRAS | A18T | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr1:115256530
- GRCh38:
- Chr1:114713909
| NRAS | Q61* | Melanoma | Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr19:3118942
- GRCh38:
- Chr19:3118944
| GNA11 | Q209L | not provided, See cases | Pathogenic/Likely pathogenic (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr19:3118942
- GRCh38:
- Chr19:3118944
| GNA11 | Q209P | Melanoma, Uveal melanoma | Pathogenic/Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr15:66782915
- GRCh38:
- Chr15:66490577
| MAP2K1, SNAPC5 | N382H, N334H | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr15:66777424
- GRCh38:
- Chr15:66485086
| MAP2K1 | P264S | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr15:66774131
- GRCh38:
- Chr15:66481793
| MAP2K1 | E203K | Inborn genetic diseases, Cardiofaciocutaneous syndrome 3 | Likely pathogenic (Jul 2, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr15:66729162
- GRCh38:
- Chr15:66436824
| MAP2K1 | P124S | RASopathy | Pathogenic (Jul 2, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr15:66729154
- GRCh38:
- Chr15:66436816
| MAP2K1 | C121S | Melanoma, Lung adenocarcinoma | Pathogenic/Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr15:66729124
- GRCh38:
- Chr15:66436786
| MAP2K1 | I111S | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr15:66727451
- GRCh38:
- Chr15:66435113
| MAP2K1 | Q56P | not provided | Pathogenic (Jul 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr15:66727441
- GRCh38:
- Chr15:66435103
| MAP2K1 | F53L | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr9:80409488
- GRCh38:
- Chr9:77794572
| GNAQ | Q209P | Melanoma, Uveal melanoma | Pathogenic/Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr9:80409488
- GRCh38:
- Chr9:77794572
| GNAQ | Q209R | Melanoma, Abnormal cardiovascular system morphology | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr9:80409488
- GRCh38:
- Chr9:77794572
| GNAQ | Q209L | Melanoma, Uveal melanoma | Pathogenic/Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453155-140453156
- GRCh38:
- Chr7:140753355-140753356
| BRAF | D594N, D506N, D542N, D557N, D560N, D572N, D597N, D634N | Melanoma, Gallbladder cancer | Pathogenic/Likely pathogenic (Oct 30, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453155
- GRCh38:
- Chr7:140753355
| BRAF | D594H, D506H, D542H, D557H, D560H, D572H, D597H, D634H | Neoplasm of the large intestine, Adrenal cortex carcinoma, Chronic lymphatic leukemia, Neoplasm of brain, Multiple myeloma, Malignant melanoma of skin, Lung adenocarcinoma, Squamous cell carcinoma of the head and neck, Melanoma, Transitional cell carcinoma of the bladder | Pathogenic/Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453154
- GRCh38:
- Chr7:140753354
| BRAF | D594V, D506V, D542V, D557V, D560V, D572V, D597V, D634V | RASopathy | Pathogenic (May 18, 2020) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- Chr7:140453153
- GRCh38:
- Chr7:140753353
| BRAF | D594E, D506E, D542E, D557E, D560E, D572E, D597E, D634E | Melanoma | Pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453153
- GRCh38:
- Chr7:140753353
| BRAF | D594E, D506E, D542E, D557E, D560E, D572E, D597E, D634E | Melanoma, Cardio-facio-cutaneous syndrome | Pathogenic/Likely pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453149
- GRCh38:
- Chr7:140753349
| BRAF | G596R, G508R, G544R, G559R, G562R, G574R, G599R, G636R | Multiple myeloma, Melanoma, Neoplasm of the large intestine, Glioblastoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma
| Pathogenic/Likely pathogenic (May 31, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453145-140453146
- GRCh38:
- Chr7:140753345-140753346
| BRAF | L597S, L509S, L545S, L560S, L563S, L575S, L600S, L637S | Melanoma | Pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453136-140453137
- GRCh38:
- Chr7:140753336-140753337
| BRAF | V600K, V512K, V548K, V563K, V566K, V578K, V603K, V640K | Trametinib-Dabrafenib Response, Vemurafenib-Cobimetinib Response | drug response | criteria provided, single submitter |
| - GRCh37:
- Chr7:140453136-140453137
- GRCh38:
- Chr7:140753336-140753337
| BRAF | V600R, V512R, V548R, V563R, V566R, V578R, V603R, V640R | Melanoma | Pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr7:140453135-140453136
- GRCh38:
- Chr7:140753335-140753336
| BRAF | V600D, V512D, V548D, V563D, V566D, V578D, V603D, V640D | Melanoma | Pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr4:55602664
- GRCh38:
- Chr4:54736498
| KIT | A829P, A825P, A824P, A826P, A828P, A830P | Gastrointestinal stroma tumor, Melanoma | Pathogenic/Likely pathogenic (Dec 26, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55599340
- GRCh38:
- Chr4:54733174
| KIT | N822K, N818K, N817K, N819K, N821K, N823K | not provided | Pathogenic (Jan 8, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55599340
- GRCh38:
- Chr4:54733174
| KIT | N822K, N818K, N817K, N819K, N821K, N823K | not provided, Gastrointestinal stroma tumor | Conflicting interpretations of pathogenicity (Aug 30, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr4:55599339
- GRCh38:
- Chr4:54733173
| KIT | N822I, N818I, N817I, N819I, N821I, N823I | Cutaneous mastocytosis, Gastrointestinal stroma tumor, Melanoma
| Pathogenic/Likely pathogenic (Jun 25, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr4:55599332
- GRCh38:
- Chr4:54733166
| KIT | D820Y, D816Y, D815Y, D817Y, D819Y, D821Y | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55599332
- GRCh38:
- Chr4:54733166
| KIT | D820H, D816H, D815H, D817H, D819H, D821H | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55594262
- GRCh38:
- Chr4:54728096
| KIT | N655K, N651K, N652K, N656K | Gastrointestinal stroma tumor | Likely pathogenic (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55594262
- GRCh38:
- Chr4:54728096
| KIT | N655K, N651K, N652K, N656K | Gastrointestinal stroma tumor | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55594261
- GRCh38:
- Chr4:54728095
| KIT | N655S, N651S, N652S, N656S | Gastrointestinal stroma tumor | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55594258
- GRCh38:
- Chr4:54728092
| KIT | V654A, V650A, V651A, V655A | Gastrointestinal stroma tumor | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55593661
- GRCh38:
- Chr4:54727495
| KIT | L576P, L572P, L573P, L577P | Gastrointestinal stroma tumor, Hereditary cancer-predisposing syndrome | Pathogenic/Likely pathogenic (Sep 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:55593640
- GRCh38:
- Chr4:54727474
| KIT | V569G, V565G, V566G, V570G | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593630
- GRCh38:
- Chr4:54727464
| KIT | N566D, N562D, N563D, N567D | Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593613
- GRCh38:
- Chr4:54727447
| KIT | V560G, V556G, V557G, V561G | Melanoma, Gastrointestinal stroma tumor | Pathogenic/Likely pathogenic (May 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593613
- GRCh38:
- Chr4:54727447
| KIT | V560A, V556A, V557A, V561A | Gastrointestinal stroma tumor | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr4:55593613
- GRCh38:
- Chr4:54727447
| KIT | V560D, V556D, V557D, V561D | Melanoma, Gastrointestinal stroma tumor | Pathogenic/Likely pathogenic (May 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593609-55593611
- GRCh38:
- Chr4:54727443-54727445
| KIT | V560del, V556del, V557del, V561del | Thymoma, Melanoma, Gastrointestinal stromal tumor, familial
| Pathogenic/Likely pathogenic (Jul 14, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593610
- GRCh38:
- Chr4:54727444
| KIT | V559G, V555G, V556G, V560G | Melanoma, Gastrointestinal stroma tumor | Pathogenic/Likely pathogenic (May 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593608
- GRCh38:
- Chr4:54727442
| KIT | K558N, K554N, K555N, K559N | Gastrointestinal stroma tumor, Melanoma | Pathogenic/Likely pathogenic (May 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593608
- GRCh38:
- Chr4:54727442
| KIT | K558N, K554N, K555N, K559N | Gastrointestinal stroma tumor | Uncertain significance (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:55593603
- GRCh38:
- Chr4:54727437
| KIT | W557R, W553R, W554R, W558R | Hereditary cancer-predisposing syndrome, Gastrointestinal stroma tumor | Pathogenic/Likely pathogenic (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr4:55593603
- GRCh38:
- Chr4:54727437
| KIT | W557R, W553R, W554R, W558R | Gastrointestinal stroma tumor, Melanoma | Pathogenic/Likely pathogenic (May 13, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr4:55593591
- GRCh38:
- Chr4:54727425
| KIT | Y553N, Y549N, Y550N, Y554N | Thymoma, Melanoma | Pathogenic (Oct 2, 2014) | no assertion criteria provided |